These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15907986)

  • 1. Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer.
    Le T; Hopkins L; Kee Fung MF
    Gynecol Oncol; 2005 Jul; 98(1):39-44. PubMed ID: 15907986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
    Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
    Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?
    Tanner EJ; Chi DS; Eisenhauer EL; Diaz-Montes TP; Santillan A; Bristow RE
    Gynecol Oncol; 2010 May; 117(2):336-40. PubMed ID: 20153027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer - a prospective nation-wide study in Finland.
    Kumpulainen S; Sankila R; Leminen A; Kuoppala T; Komulainen M; Puistola U; Hurme S; Hiekkanen H; Mäkinen J; Grénman S
    Gynecol Oncol; 2009 Nov; 115(2):199-203. PubMed ID: 19695688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Skírnisdóttir I; Lindborg K; Sorbe B
    Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life assessments in epithelial ovarian cancer patients during and after chemotherapy.
    Le T; Hopkins L; Fung Kee Fung M
    Int J Gynecol Cancer; 2005; 15(5):811-6. PubMed ID: 16174229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in ovarian cancer patients receiving chemotherapy.
    Lakusta CM; Atkinson MJ; Robinson JW; Nation J; Taenzer PA; Campo MG
    Gynecol Oncol; 2001 Jun; 81(3):490-5. PubMed ID: 11371144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance to consensus recommendations, surgeon's experience, and introduction of a quality assurance and management program: influence on therapy of early-stage ovarian carcinoma.
    Kommoss S; Harter P; Traut A; Strutas D; Riegler N; Buhrmann C; Gomez R; du Bois A
    Int J Gynecol Cancer; 2009 May; 19(4):787-93. PubMed ID: 19509589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer.
    Case AS; Rocconi RP; Partridge EE; Straughn JM
    Gynecol Oncol; 2007 Apr; 105(1):223-7. PubMed ID: 17215031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.
    Tanner EJ; Black DR; Zivanovic O; Kehoe SM; Dao F; Konner JA; Barakat RR; Lichtman SM; Levine DA
    Gynecol Oncol; 2012 Jan; 124(1):59-62. PubMed ID: 21982046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6).
    Wagner U; du Bois A; Pfisterer J; Huober J; Loibl S; Lück HJ; Sehouli J; Gropp M; Stähle A; Schmalfeldt B; Meier W; Jackisch C;
    Gynecol Oncol; 2007 Apr; 105(1):132-7. PubMed ID: 17161453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Blumenson LE
    Gynecol Oncol; 1998 Nov; 71(2):190-5. PubMed ID: 9826459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.
    Pokrzywinski R; Secord AA; Havrilesky LJ; Puls LE; Holloway RW; Lewandowski GS; Higgins RV; Nycum LR; Kohler MF; Revicki DA
    Gynecol Oncol; 2011 Dec; 123(3):505-10. PubMed ID: 21945310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
    Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
    Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?
    Kolomainen DF; A'Hern R; Coxon FY; Fisher C; King DM; Blake PR; Barton DP; Shepherd JH; Kaye SB; Gore ME
    J Clin Oncol; 2003 Aug; 21(16):3113-8. PubMed ID: 12915602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential platelet levels affect response to taxane-based therapy in ovarian cancer.
    Bottsford-Miller J; Choi HJ; Dalton HJ; Stone RL; Cho MS; Haemmerle M; Nick AM; Pradeep S; Zand B; Previs RA; Pecot CV; Crane EK; Hu W; Lutgendorf SK; Afshar-Kharghan V; Sood AK
    Clin Cancer Res; 2015 Feb; 21(3):602-10. PubMed ID: 25473001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.